Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
Clinical Colorectal Cancer
|
February 8, 2024
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh, et al.
ESMO Open
|
February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Daisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
International Journal of Clinical Oncology
|
February 7, 2025
Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing
Shin Kobayashi, Yoshiaki Nakamura, Tadayoshi Hashimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2022
Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy
Keigo Chida, Akihito Kawazoe, Toshihiro Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
February 7, 2023
Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
Takumi Habu, Ryosuke Kumanishi, Takatsugu Ogata, et al.
Cancer Science
|
July 25, 2022
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
Mitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, et al.
JCO Precision Oncology
|
April 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for <i>HER2</i>-Amplified Advanced Biliary Tract Cancer
Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey, et al.
JCO Precision Oncology
|
July 1, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study
Tatsuro Murano, Hiroaki Ikematsu, Nobuhisa Matsuhashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer
Hideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
Clinical Colorectal Cancer
|
February 8, 2024
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh, et al.
ESMO Open
|
February 8, 2021
BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Daisuke Kotani, Hideaki Bando, Hiroya Taniguchi, et al.
International Journal of Clinical Oncology
|
February 7, 2025
Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing
Shin Kobayashi, Yoshiaki Nakamura, Tadayoshi Hashimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2022
Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy
Keigo Chida, Akihito Kawazoe, Toshihiro Suzuki, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
February 7, 2023
Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
Takumi Habu, Ryosuke Kumanishi, Takatsugu Ogata, et al.
Cancer Science
|
July 25, 2022
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
Mitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, et al.
JCO Precision Oncology
|
April 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for <i>HER2</i>-Amplified Advanced Biliary Tract Cancer
Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey, et al.
JCO Precision Oncology
|
July 1, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study
Tatsuro Murano, Hiroaki Ikematsu, Nobuhisa Matsuhashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer
Hideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.
Page
of 19